Sept 21 (Reuters) - Collplant Biotechnologies Ltd CPTGy.F :
* COLLPLANT AND UNITED THERAPEUTICS ANNOUNCE EXERCISE OF
OPTION
THAT WILL EXPAND THEIR COLLABORATION TO INCLUDE 3D BIOPRINTING
OF HUMAN KIDNEYS FOR TRANSPLANT
* UNITED THERAPEUTICS CORP - PAID COLLPLANT $3 MILLION FOR
OPTION
EXERCISE
* UNITED THERAPEUTICS CORP - COLLPLANT RECEIVED AN UPFRONT
PAYMENT
OF $5 MILLION AND WILL RECEIVE MILESTONE PAYMENTS OF UP TO $15
MILLION
* UNITED THERAPEUTICS - COLLPLANT WILL ALSO BE ENTITLED TO
ROYALTIES ON SALES OF COMMERCIALIZED PRODUCTS COVERED BY PATENTS
LICENSED FROM COLLPLANT
Source text for Eikon: ID:nPnbFgndRa
Further company coverage: CPTGy.F
((Reuters.Briefs@thomsonreuters.com;))